Frontier Home Health And Hospice 3909 Arctic Blvd Suite 102, Anchorage, AK, 99503 | |
(907) 272-1275 |
News Archive
Mirjana Maletic-Savatic, M.D., Ph.D, and co-investigators from Stony Brook University Medical Center, Brookhaven National Laboratory and Cold Spring Harbor Laboratory have discovered a way to image a biomarker of neural stem and progenitor cells (NPCs) in the living human brain.
Massachusetts General Hospital researchers have found that extracellular RNA in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.
As the SARS-CoV-2 continues to spread worldwide and cause disease and death on a devastating scale, genomic sequencing has become a primary method of keeping track of emerging variants and new outbreaks. A new medRxiv* preprint explores the role of nanopore sequencing in this effort.
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.
More than 140 delegates from 45 countries have joined the International Osteoporosis Foundation and the Finnish Osteoporosis Association for the 14th IOF Worldwide Conference of Osteoporosis Patient Societies.
› Verified 2 days ago
Name | Frontier Home Health And Hospice |
---|---|
Location | 3909 Arctic Blvd Suite 102, Anchorage, Alaska |
Hospice ID | 021508 |
Category | Freestanding Hospice |
Ownership Type | Other |
Profit Type | OTHER |
SSA county code | 020 |
News Archive
Mirjana Maletic-Savatic, M.D., Ph.D, and co-investigators from Stony Brook University Medical Center, Brookhaven National Laboratory and Cold Spring Harbor Laboratory have discovered a way to image a biomarker of neural stem and progenitor cells (NPCs) in the living human brain.
Massachusetts General Hospital researchers have found that extracellular RNA in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.
As the SARS-CoV-2 continues to spread worldwide and cause disease and death on a devastating scale, genomic sequencing has become a primary method of keeping track of emerging variants and new outbreaks. A new medRxiv* preprint explores the role of nanopore sequencing in this effort.
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.
More than 140 delegates from 45 countries have joined the International Osteoporosis Foundation and the Finnish Osteoporosis Association for the 14th IOF Worldwide Conference of Osteoporosis Patient Societies.
› Verified 2 days ago
NPI Number | 1659345734 |
Organization Name | Integricare, Inc. |
Address | 3935 Reka Dr Anchorage, Alaska, 99508 |
Phone Number | (907)272-1275 |
News Archive
Mirjana Maletic-Savatic, M.D., Ph.D, and co-investigators from Stony Brook University Medical Center, Brookhaven National Laboratory and Cold Spring Harbor Laboratory have discovered a way to image a biomarker of neural stem and progenitor cells (NPCs) in the living human brain.
Massachusetts General Hospital researchers have found that extracellular RNA in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.
As the SARS-CoV-2 continues to spread worldwide and cause disease and death on a devastating scale, genomic sequencing has become a primary method of keeping track of emerging variants and new outbreaks. A new medRxiv* preprint explores the role of nanopore sequencing in this effort.
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.
More than 140 delegates from 45 countries have joined the International Osteoporosis Foundation and the Finnish Osteoporosis Association for the 14th IOF Worldwide Conference of Osteoporosis Patient Societies.
› Verified 2 days ago
NPI Number | 1831595685 |
Organization Name | Frontier Home Health And Hospice, Llc |
Address | 3909 Artic Blvd Anchorage, Alaska, 99503 |
Phone Number | (907)272-1275 |
News Archive
Mirjana Maletic-Savatic, M.D., Ph.D, and co-investigators from Stony Brook University Medical Center, Brookhaven National Laboratory and Cold Spring Harbor Laboratory have discovered a way to image a biomarker of neural stem and progenitor cells (NPCs) in the living human brain.
Massachusetts General Hospital researchers have found that extracellular RNA in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.
As the SARS-CoV-2 continues to spread worldwide and cause disease and death on a devastating scale, genomic sequencing has become a primary method of keeping track of emerging variants and new outbreaks. A new medRxiv* preprint explores the role of nanopore sequencing in this effort.
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.
More than 140 delegates from 45 countries have joined the International Osteoporosis Foundation and the Finnish Osteoporosis Association for the 14th IOF Worldwide Conference of Osteoporosis Patient Societies.
› Verified 2 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Mirjana Maletic-Savatic, M.D., Ph.D, and co-investigators from Stony Brook University Medical Center, Brookhaven National Laboratory and Cold Spring Harbor Laboratory have discovered a way to image a biomarker of neural stem and progenitor cells (NPCs) in the living human brain.
Massachusetts General Hospital researchers have found that extracellular RNA in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.
As the SARS-CoV-2 continues to spread worldwide and cause disease and death on a devastating scale, genomic sequencing has become a primary method of keeping track of emerging variants and new outbreaks. A new medRxiv* preprint explores the role of nanopore sequencing in this effort.
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.
More than 140 delegates from 45 countries have joined the International Osteoporosis Foundation and the Finnish Osteoporosis Association for the 14th IOF Worldwide Conference of Osteoporosis Patient Societies.
› Verified 2 days ago
Home Health Aides | 1 |
Counselors | 1 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 2 |
Other Personnel | 6 |
Total Employees | 12 |
---|
News Archive
Mirjana Maletic-Savatic, M.D., Ph.D, and co-investigators from Stony Brook University Medical Center, Brookhaven National Laboratory and Cold Spring Harbor Laboratory have discovered a way to image a biomarker of neural stem and progenitor cells (NPCs) in the living human brain.
Massachusetts General Hospital researchers have found that extracellular RNA in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.
As the SARS-CoV-2 continues to spread worldwide and cause disease and death on a devastating scale, genomic sequencing has become a primary method of keeping track of emerging variants and new outbreaks. A new medRxiv* preprint explores the role of nanopore sequencing in this effort.
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.
More than 140 delegates from 45 countries have joined the International Osteoporosis Foundation and the Finnish Osteoporosis Association for the 14th IOF Worldwide Conference of Osteoporosis Patient Societies.
› Verified 2 days ago
Providence In Home Services Location: 4001 Dale Street, Suite 101, Anchorage, Alaska, 99508 Phone: (907) 272-1275 |
Frontier Home Health And Hospice Location: 3909 Arctic Blvd Suite 102, Anchorage, Alaska, 99503 Phone: (907) 272-1275 |